FDA Approves New Immunotherapy for Endometrial Cancer ...Middle East

Medscape - News
The accelerated approval for dostarlimab is for use in patients with recurrent or advanced endometrial cancers with deficient mismatch repair (dMMR). FDA Approvals

Hence then, the article about fda approves new immunotherapy for endometrial cancer was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves New Immunotherapy for Endometrial Cancer )

Apple Storegoogle play

Last updated :

Also on site :